Home › GlaxoSmithKline's experimental HIV, AIDS drug to get priority review
 

Keywords :   


GlaxoSmithKline's experimental HIV, AIDS drug to get priority review

2013-02-19 02:02:39| Biotech - Topix.net

U.S. regulators gave priority review status to an experimental GlaxoSmithKline drug for HIV/AIDS, which industry analysts view as a possible multibillion-dollar-a-year seller.

Tags: review drug aids priority

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
07.10Hurricane Milton Probabilistic Storm Surge Graphics
07.10Customers of failed crypto firm FTX set for refunds
07.10Hurricane Milton Graphics
07.10Hurricane Milton Storm Surge Watch/Warning Map
07.10Hurricane Milton Forecast Advisory Number 11
07.10Hurricane Leslie Graphics
07.10Hurricane Leslie Wind Speed Probabilities Number 22
07.10Hurricane Leslie Public Advisory Number 22
More »